, , , , ,

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

By

rongyao

|

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer下载

免责声明：本网站目的在于科普相关知识传播，非盈利性质，全部资料均来源于网络，如有侵权请联系删除！